These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 165942)

  • 1. Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor.
    Jordan VC; Koerner S
    Eur J Cancer (1965); 1975 Mar; 11(3):205-6. PubMed ID: 165942
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
    Horner-Glister E; Maleki-Dizaji M; Guerin CJ; Johnson SM; Styles J; White IN
    J Mol Endocrinol; 2005 Dec; 35(3):421-32. PubMed ID: 16326830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
    Jordan VC; Dowse LJ
    J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oestradiol binding to oestrogen receptor proteins by a methyl-substituted analogue of tamoxifen.
    Abbott AC; Clark ER; Jordan VC
    J Endocrinol; 1976 Jun; 69(3):445-6. PubMed ID: 181517
    [No Abstract]   [Full Text] [Related]  

  • 5. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
    Nicholson RI; Syne JS; Daniel CP; Griffiths K
    Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of o, p'DDT with the estrogen-binding protein (EBP) in human mammary and uterine tumors.
    Kupfer D; Bulger WH
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):451-62. PubMed ID: 847298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.
    Jordan VC; Prestwich G
    Mol Cell Endocrinol; 1977 Sep; 8(3):179-88. PubMed ID: 924012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the estimation of oestrogen receptors in human malignant breast tumours.
    Braunsberg H
    Eur J Cancer (1965); 1975 Jul; 11(7):499-507. PubMed ID: 172334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen receptor in human endometrium--energy requirement, stability and subunit structure-- (author's transl)].
    Ozaki M; Kurachi K
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):774-83. PubMed ID: 1035170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone "receptor" in human endometrium.
    Rao BR; Wiest WG; Allen WM
    Endocrinology; 1974 Nov; 95(5):1275-81. PubMed ID: 4372036
    [No Abstract]   [Full Text] [Related]  

  • 11. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
    Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of steroid hormones and tamoxifen on the rate of phospholipid turnover in the cells of uterine and breast tumors].
    Krasil'nikov MA; Shatskaia VA; Kuz'mina ZV; Barinov VV; Letiagin VP; Bassalyk LS
    Vestn Ross Akad Med Nauk; 1993; (3):43-7. PubMed ID: 7687911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Effects of oestradiol-17 beta and ICI 46,474 on total and accessible cytoplasmic oestradiol-17 beta receptors in dimethylbenzanthracene-induced rat mammary tumours.
    Nicholson RI; Golder MP; Davies P; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):50P-51P. PubMed ID: 181519
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitation of estrogen receptor in mammary carcinoma.
    McGuire WL
    Methods Enzymol; 1975; 36():248-54. PubMed ID: 162982
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of progesterone and tamoxifen on EGF-dependent activation of phospholipid turnover in uterine and breast tumor cells].
    Krasil'nikov MA; Shatskaia VA; Bassalyk LS
    Biokhimiia; 1993 Jun; 58(6):967-74. PubMed ID: 8364119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of tamoxifen with cytosol estradiol receptors in myoma and histologically unchanged myometrium].
    Kareva EN; Kostyleva OI
    Biull Eksp Biol Med; 1993 Mar; 115(3):264-5. PubMed ID: 8054615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-induced increase in cytosol progestin receptor levels in a case of metastatic endometrial cancer.
    Schwartz PE; MacLusky N; Naftolin F; Eisenfeld A
    Gynecol Oncol; 1983 Aug; 16(1):41-8. PubMed ID: 6884830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Cytosol estradiol receptors in 143 human female breast adenocarcinoma (author's transl)].
    Saez S; Sakai F; Chouvet C
    Ann Endocrinol (Paris); 1974; 35(6):661-2. PubMed ID: 4377079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid binding properties of estradiol receptors in human breast cancer.
    Jänne O; Kontula K; Vihko R; Pystynen P; Auvinen O; Lauslahti K
    Med Biol; 1975 Aug; 53(4):214-23. PubMed ID: 171527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.